← Leaderboards
Leon Dejournett
Ideal Medical Technologies, Inc.
$1,889,276
Attributed
$1,889,276
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $958.2K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,889,276 · 1
By mechanism
R44$1,889,276 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Efficacy Study”
- Angee Greer · Ppd Development Lp$82,531,927
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Suma Babu · Massachusetts General Hospital$26,348,733
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
Research focus
Efficacy StudyEfficacy TrialArtificial IntelligenceAdultArtificial PancreasAdmission ActivityBlood GlucoseBlood Glucose RegulationClinical TrialsArtificial Intelligence AlgorithmCommercializationComputer SoftwareAlgorithmsCovid-19 PandemicCritical IllnessCyber SecurityDesignDevicesDiabeticDiscipline Of NursingDoseCollaborationsEffectiveness EvaluationEngineering
Grant awards (2)
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System$931,064
R44 · FY2023 · DK · contact PI
Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System$958,212
R44 · FY2022 · DK · contact PI